Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.008 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.15 | 0.009 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |